Activating Compound | Comment | Organism | Structure |
---|---|---|---|
4-[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]benzaldehyde | 138% residual activity at 0.01 mM | Homo sapiens | |
4-[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]phenol | 125% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2,8-dimethyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 126% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-8-(4-phenoxyphenyl)-9H-purin-6-amine | 112% activity at 0.01 mM | Homo sapiens | |
[4-[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]phenyl]methanol | 103% residual activity at 0.01 mM | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-[3-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]phenyl]-2-methylpropan-1-one | 16% residual activity at 0.01 mM | Homo sapiens | |
2-(3-chlorophenyl)-9-(3,4-dimethoxyphenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 67% residual activity at 0.01 mM | Homo sapiens | |
3-(3,4-dimethoxyphenyl)-2,5-dimethyl-N-[2-(morpholin-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine | - |
Homo sapiens | |
3-(3,4-dimethoxyphenyl)-5-methyl-N-[2-(morpholin-4-yl)ethyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine | 31% residual activity at 0.01 mM | Homo sapiens | |
3-(3,4-dimethoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine | 41% residual activity at 0.01 mM | Homo sapiens | |
4-[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]benzonitrile | 97% residual activity at 0.01 mM | Homo sapiens | |
4-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]benzonitrile | 97% residual activity at 0.01 mM | Homo sapiens | |
4-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]phenol | 18% residual activity at 0.01 mM | Homo sapiens | |
7-(3,4-dimethoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 74% residual activity at 0.01 mM | Homo sapiens | |
8-(cyclohex-3-en-1-yl)-9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 75% residual activity at 0.01 mM | Homo sapiens | |
8-bromo-9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 17% residual activity at 0.01 mM | Homo sapiens | |
8-cyclohexyl-9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 79% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2,8-dimethyl-N-[2-(morpholin-4-yl)ethyl]-5,9-dihydro-4H-purin-6-amine | 14% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-(4-fluorophenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 66% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-ethynyl-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 18% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-iodo-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 33% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methoxy-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 15% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-8-(3-phenylprop-1-yn-1-yl)-9H-purin-6-amine | 96% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-8-(propan-2-yl)-9H-purin-6-amine | 65% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-8-(thiophen-3-yl)-9H-purin-6-amine | 94% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-8-(trifluoromethyl)-9H-purin-6-amine | 99% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 26% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-(4-fluorophenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 78% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-iodo-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 38% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methoxy-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 86% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purine-2-carbonitrile | 24% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-2-(3-phenylprop-1-yn-1-yl)-9H-purin-6-amine | 58% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-2-(pyridin-3-yl)-9H-purin-6-amine | 36% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-2-(thiophen-3-yl)-9H-purin-6-amine | 46% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | 13% residual activity at 0.01 mM | Homo sapiens | |
9-(3,4-dimethoxyphenyl)-8-methyl-N6-[2-(morpholin-4-yl)ethyl]-9H-purine-2,6-diamine | 25% residual activity at 0.01 mM | Homo sapiens | |
N-[3-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]phenyl]acetamide | 14% residual activity at 0.01 mM | Homo sapiens | |
PIK93 | - |
Homo sapiens | |
T-00127-HEV1 | - |
Homo sapiens | |
[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]methanol | 62% residual activity at 0.01 mM | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 1-phosphatidyl-1D-myo-inositol | Homo sapiens | - |
ADP + 1-phosphatidyl-1D-myo-inositol 4-phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 1-phosphatidyl-1D-myo-inositol | - |
Homo sapiens | ADP + 1-phosphatidyl-1D-myo-inositol 4-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
phosphatidylinositol 4-kinase IIIbeta | - |
Homo sapiens |
PI 4-kinase | - |
Homo sapiens |
PI4K IIIbeta | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00091 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 9-(3,4-dimethoxyphenyl)-2,8-dimethyl-N-[2-(morpholin-4-yl)ethyl]-5,9-dihydro-4H-purin-6-amine | |
0.00109 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 1-[3-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]phenyl]-2-methylpropan-1-one | |
0.00144 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 9-(3,4-dimethoxyphenyl)-8-methyl-N6-[2-(morpholin-4-yl)ethyl]-9H-purine-2,6-diamine | |
0.00161 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 9-(3,4-dimethoxyphenyl)-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | |
0.00191 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 9-(3,4-dimethoxyphenyl)-2-ethynyl-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | |
0.00207 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purine-2-carbonitrile | |
0.00214 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | N-[3-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]phenyl]acetamide | |
0.00237 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 4-[9-(3,4-dimethoxyphenyl)-8-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-2-yl]phenol | |
0.00299 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 9-(3,4-dimethoxyphenyl)-2-methoxy-8-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine | |
0.0052 | - |
isoform PI4K IIIbeta, pH and temperature not specified in the publication | Homo sapiens | 8-bromo-9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine |